Fundz

Who to call at Replimune, and when

Fundz watches for the moments Replimune starts buying, and tells you who to reach.

  • An alert the day Replimune raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Replimune, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Replimune. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchReplimune Group, Inc. advances cancer treatment with the submission of RP1 Biologics License Application and receives Breakthrough Therapy designation.

Nov 21, 2024
WoburnBiotechnologyHealth Care

Product Description

Replimune Group, Inc. announced the submission of a biologics license application for RP1, an innovative treatment for advanced melanoma, to the FDA under the Accelerated Approval pathway and has received Breakthrough Therapy designation.

Company Information

Company

Replimune

Location

Woburn, Massachusetts, United States

About

Replimune is working to advance the science of oncolytic immunotherapy to improve on existing therapies and help treat more patients with a variety of tumor types. Oncolytic immunotherapy uses viruses that have been modified to selectively replicate in and kill tumors. Replimunes'​ goal is to develop powerful therapies to overcome cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Replimune ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Replimune's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Replimune shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.